Gynecology and Minimally Invasive Therapy

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 7  |  Issue : 1  |  Page : 10--15

The changes of surgical treatment for symptomatic uterine myomas in the past 15 Years


Weihong Yang1, Ning Luo1, Lishan Ma2, Hong Dai2, Zhongping Cheng1 
1 Department of Gynecology and Obstetrics, Tenth People's Hospital; Department of Gynecology, Gynecologic Minimally Invasive Surgery Research Center, Tongji University School of Medicine, Shanghai, P.R.China
2 Department of Gynecology, Gynecologic Minimally Invasive Surgery Research Center; Department of Obstetrics and Gynecology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, P.R.China

Correspondence Address:
Dr. Zhongping Cheng
Director of Department of Gynecology and Obstetrics, Tenth People's Hospital, Tongji University School of Medicine, 301, Yan Chang Road, 200072, Shanghai
P.R.China

Study Objective: The aim of this study is to elaborate the changes of the surgical approach of treatment for uterine myomas in Yangpu Hospital in the past 15 years. Design: This was retrospective cohort study. Setting: Yangpu Hospital, Tongji University School of Medicine, Shanghai, China. Materials and Methods: A total of 4113 patients with symptomatic uterine myomas underwent surgical treatments. Interventions: Eight kinds of different surgeries were involved in the study, including abdominal or laparoscopic surgery, hysterectomy, or uterus-sparing myomectomy. Measurements: The study collected patients' clinical data and reviewed surgical access and approach, complications, and the results of following up. Results: A total of 1559 cases (37.9%) underwent uterus-sparing myomectomy, 3005 cases (73.1%) performed laparoscopic surgeries. The percentage of laparoscopic surgery was significantly higher than homochronous data of laparotomy after 2003 (P < 0.001). The per year total of uterus-reserved surgery was proved to be negatively correlated with patient's age (R2 = 0.930; P < 0.001). The rate of myomas recurrence was significantly lower in the combined myomectomy and uterine artery occlusion group (4%, 34/910) than in the single myomectomy group (10.5%, 44/420) (P < 0.001). Conclusions: Retaining uterus and minimally invasive surgery were the important trends of surgical treatment for symptomatic uterine myomas. Laparoscopic uterus-sparing myomectomy may be an alternative to hysterectomy to manage to appropriate patients with uterine myomas.


How to cite this article:
Yang W, Luo N, Ma L, Dai H, Cheng Z. The changes of surgical treatment for symptomatic uterine myomas in the past 15 Years.Gynecol Minim Invasive Ther 2018;7:10-15


How to cite this URL:
Yang W, Luo N, Ma L, Dai H, Cheng Z. The changes of surgical treatment for symptomatic uterine myomas in the past 15 Years. Gynecol Minim Invasive Ther [serial online] 2018 [cited 2023 Jan 28 ];7:10-15
Available from: https://www.e-gmit.com/article.asp?issn=2213-3070;year=2018;volume=7;issue=1;spage=10;epage=15;aulast=Yang;type=0